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ABSTRACT
Background: Long QT syndrome (LQTS) is characterized by QT prolongation, syncope and sudden death. This 
study aims to explore the causes, clinical manifestations and therapeutic outcomes of Jervell and Lange-Nielsen 
syndrome (JLNS), a rare form of LQTS with congenital sensorineural deafness, in Chinese individuals. Materials 
and Methods: Three JLNS kindreds from the Chinese National LQTS Registry were investigated. Mutational 
screening of KCNQ1 and KCNE1 genes was performed by polymerase chain reaction and direct DNA sequence 
analysis. LQTS phenotype and therapeutic outcomes were evaluated for all probands and family members. Results: 
We identified 7 KCNQ1 mutations. c.1032_1117dup (p.Ser373TrpfsX10) and c.1319delT (p.Val440AlafsX26) 
were novel, causing JLNS in a 16-year-old boy with a QTc (QT interval corrected for heart rate) of 620 ms and 
recurrent syncope. c.605-2A>G and c.815G>A (p.Gly272Asp) caused JLNS in a 12-year-old girl and her 5-year-old 
brother, showing QTc of 590 to 600 ms and recurrent syncope. The fourth JLNS case, a 46-year-old man carrying 
c.1032G>A (p.Ala344Alasp) and c.569G>A (p.Arg190Gln) and with QTc of 460 ms, has been syncope-free since 
age 30. His 16-year-old daughter carries novel missense mutation c.574C>T (p.Arg192Cys) and c.1032G>A(p.
Ala344Alasp) and displayed a severe phenotype of Romano-Ward syndrome (RWS) characterized by a QTc of 530 
ms and recurrent syncope with normal hearing. Both the father and daughter also carried c.253G>A (p.Asp85Asn; 
rs1805128), a rare single nucleotide polymorphism (SNP) on KCNE1. Bizarre T waves were seen in 3/4 JLNS 
patients. Symptoms were improved and T wave abnormalities became less abnormal after appropriate treatment. 
Conclusion: This study broadens the mutation and phenotype spectrums of JLNS. Compound heterozygous 
KCNQ1 mutations can result in both JLNS and severe forms of RWS in Chinese individuals.
Key words: Compound heterozygous mutation, frameshift mutation, Jervell and Lange-Nielsen 
syndrome, KCNQ1, KCNE1, long QT syndrome, Romano-Ward syndrome, single nucleotide polymorphism
Genotype-phenotype analysis of three Chinese families with 
Jervell and Lange-Nielsen syndrome
Yuanfeng Gao, Cuilan Li, Wenling Liu, Robby Wu1, Xiaoliang Qiu, Ruijuan Liang, Lei Li, 
Li Zhang2, Dayi Hu
Heart Center, Peking University People’s Hospital, Beijing – 100 044, P. R. China, 1Philadelphia College 
of Osteopathic Medicine, 2Lankenau Medical Center, Lankenau Institute for Medical Research, Jefferson 
Medical College, Philadelphia, U.S.A.
Address for correspondence: Dr. Cuilan Li, Heart Center, Peking University People’s Hospital,  
Beijing – 100 044, P. R. China. E-mail: licuilan@gmail.com
JCDR
arrhythmias, syncope and sudden death (SD). Two forms 
of LQTS have been classified: Autosomal dominant 
Romano-Ward syndrome (RWS), which presents without 
hearing deficiency, and the more rarely occurring autosomal 
recessive Jervell and Lange-Nielsen syndrome (JLNS), 
which presents with congenital sensorineural deafness.
Physiologically, the slowly activating delayed rectifier 
K+ current (IKs) is crucial in maintaining the cardiac 
responses that generate a normal T wave and QT interval. 
Proteins encoded by the KCNQ1 and KCNE1 genes co-
assemble to form IKs potassium channels.[1,2] Homozygous 
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or compound heterozygous mutations of either KCNQ1 
or KCNE1 can result in JLNS.[3-6] Single heterozygous 
mutations found in ≥13 genes, on the other hand, cause 
RWS and account for the vast majority of LQTS.[7,8]
Severe phenotypes are often seen in patients carrying more 
than one LQTS-causing mutations. Such a “cumulative effect,” 
occurring as either homozygous or compound heterozygous 
mutations, can severely impair or even completely obliterate 
functional expression of IKs, resulting in severe variants of 
LQTS. Patients with JLNS often present with early onset of 
cardiac events, bizarre T waves and marked QTc (QT interval 
corrected for heart rate) prolongation. Beta-blockers, the first 
line therapy of LQTS, generally provide limited protection to 
JLNS patients.[9] Malfunction, or complete loss of function 
of IKs in the inner ear is the underlying cause of the auditory 
impairment or sensorineural deafness in JLNS.
Among reported mutations associated with JLNS,[7,10-13] 
three of 31 cases were found in Chinese individuals and 
include homozygous mutation T322M[12] and a compound 
heterozygous mutation T2C/1149insT in KCNQ1.  [13] In this 
study, we report seven additional compound heterozygous 
mutations in KCNQ1 and one rare SNP on KCNE1, 
identified in three Chinese JLNS kindreds.
MATERIALS AND METHODS
Study subjects
Three JLNS kindreds, two of Han and one of Miao 
descent, selected from 160 LQTS families in the Chinese 
Channelopathy Registry, were enrolled into this study.
Written consents, approved by the Ethics Committee 
of Peking University People’s Hospital, were obtained 
from participants. Individuals were diagnosed with JLNS 
based on QT prolongation in the presence of profound 
sensorineural deafness. Phenotype characteristics were 
determined by the presence or absence of syncope and 
precipitating factors, age at first cardiac event, and changes 
in T wave morphology before and after therapies.
Mutation analysis
Genomic DNA from patients and family members was 
extracted from whole blood. All samples underwent 
polymerase chain reaction (PCR) amplification and direct 
sequencing in accordance to standard protocols (94°C for 
3 minutes, followed by 30 cycles of 94°C for 10 seconds, 
58°C for 20 seconds, and 72°C for 20 seconds, and a 
5 minute extension at 72°C).[4] The sequence of PCR primer 
pairs was based on reference or re-designed using Primer 3 
online (KCNQ1: NM_000218.2; KCNE1: NM_000219.3) 
to flank all exons and intron-exon junctions (suppl.1). PCR 
amplification was carried out using standard protocols for all 
samples with the exception of exon 1c, which was amplified 
with the GC RICH PCR system (Roche, Rotkreuz, Zug, 
Switzerland) due to its high GC content. PCR products 
were purified by vacuum pump Axygen PCR (Microplate, 
Winooski, USA). Direct sequencing was carried out with 
BigDye Terminator (Applied Biosystems, Foster City, 
California, U.S.A) DNA sequencing kit (version 3.1) and 
3730XL DNA Analyzer (Applied Biosystems, Foster City, 
California, U.S.A). DNA samples from 50 healthy Han 
Chinese volunteers were used as controls. The mutation data 
were recorded onto a publicly available database LOVD[7] 
and the accession numbers are: KCNQ1_00582, 00583, 
00584, 00585, 00586, 00587, 0589.
Nomenclature of new mutations
LQTS-causing mutations and other variants were denoted 
using known and accepted nomenclature. The numbering 
for all mutations started at the ATG initiation codon of 
the full-length isoform 1 of KCNQ1. The exon numbering 
was labeled according to Splawski et al.[14] Frameshift 
mutations resulting from nucleotide insertions or deletions 
were annotated using the p.Ser6ProfsX2 format. Here, 
p.Ser6ProfsX2 denotes a frameshift change with Serine 6 
as the first affected amino acid, changing into a Proline and 
the new reading frame ending with stop codon X at position 
2 in the shifted reading frame.[15] A substitution of either 
the first or the last two nucleotides of a particular exon has 
the capacity to alter proper mRNA splicing, regardless of 
whether the nucleotide substitution codes for a different 
amino acid (missense mutation), produces a stop codon 
(nonsense mutation) or does not alter the open reading 
frame at all (i.e., a synonymous or silent single nucleotide 
substitution).
Electrocardiogram (ECG) parameters
The paper speed for all ECGs was 25 mm/s. Each QT 
interval was defined as the interval between the onset of 
the Q wave and the end of the T wave, and was based 
upon the mean of 2–3 consecutive heart beats on leads 
II, V5 or on any of the 12 leads where the QT interval 
appeared to be the longest. Heart rate-corrected QT (QTc) 
was calculated using Bazett’s formula (QT/√RR), and a 
diagnosis of LQTS was considered when QTc was ≥0.47 
s for males and ≥0.48 s for females. A QTc in the range 
of 0.44–0.47 s was considered borderline.[16,17] Bifid T 
waves were included and U waves were excluded in the 
QT measurements.Journal of Cardiovascular Disease Research Vol. 3 / No 2 69
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RESULTS
KCNQ1 gene screening in three Chinese JLNS kindreds 
revealed six disease-causing mutations responsible for 
JLNS and one novel mutation resulting in RWS. Four 
mutations previously reported in RWS caused JLNS in our 
patients when formed as compound mutations [Table 1].
Clinical characteristics and mutation findings in 
Family L148
Family L148 consisted of two asymptomatic parents and 
their two profoundly deaf children, a 12-year-old girl and 
a 5-year-old boy.
The young siblings presented with recurrent syncope starting 
at age 2, and markedly prolonged QTc intervals (590 ms and 
600 ms, respectively) [Figure 1] at time of JLNS diagnosis. 
No consanguineous marriage was identified in the family 
and both parents had normal QT intervals. Prior to LQTS 
therapy, both deaf children experienced approximately 5–6 
syncopal episodes per year, mostly triggered by emotional 
stress or physical exercise, including one reported incidence 
from the girl during 2008’s Wenchuan Earthquake. 
Considering the severity of their LQTS phenotype, both 
children were treated with beta-blockers (Propranolol,   
2.1–2.5 mg/kg/day) and left cardiac sympathetic 
denervation (LCSD) in 2009. The girl reported one 
episode and the boy reported three episodes of syncope at 
the 2-year follow-up. Due to financial constraints and the 
possibility of unwarranted side effects, their parents refused 
installation of an implantable cardioverter defibrillator 
(ICD).
Compound heterozygous mutations, c.605-2A>G a 
splicing mutation and c.815G>A (p.Gly272Asp), a 
missense mutation of KCNQ1, were identified in these two 
siblings. Family genotyping revealed that the father carried 
Table 1:  Genotype-phenotype correlation in three kindreds with JLNS
ID Sex Deafness SD First event 
age
Syncope frequency 
(time/year)
QTc (ms) Mutations Mutation type
Kindred L148
I:1 M N N N 0 432 c.605-2A>G FS/splice
I:2 F N N N 0 418 none N
I:3 M N N N 0 411 c.815G>A Missense
I:4 F N N N 0 448 none N
II:1 F N N N 0 437 none N
II:2 F N N N 0 448 c.605-2A>G FS/splice
II:3 M N N N 0 410 c.815G>A Missense
II:4 M N N N 0 387 none N
II:5 F N N N 0 453 c.815G>A Missense
III:1# F Y N 2 5-6 590 c.815G>A; 
c.605-2A>G
FS/splice; 
missense
III:2# M Y N 2 5-6 600 c.815G>A; 
c.605-2A>G
FS/splice; 
missense
Kindred L151
I:1 M N N N 0 506 c.1032G>A FS/splice
I:2 F N N N 0 506 c.569G>A    
D85N-KCNE1
Missense; rare 
SNP
II:1# M Y N 2 1-2¶ 465 c.1032G>A; 
c.569G>A; 
D85N-KCNE1
FS/splice; 
missense;  
rare SNP
II:2 F N N N 0 411 c.574C>T Missense
II:3 F N N N 0 388  D85N-KCNE1 Rare SNP
II:4 F Y Y N 0 ND ND ND
III:1 F N N 2 1-2 480 c.1032G>A; 
c.574C>T; 
D85N-KCNE1
FS/splice; 
missense; rare 
SNP
Kindred L155
I:1 M N N N 0 406 c.1319delT FS/del
I:2 F N N N 0 444 c.1032_1117dup FS/dup
II:1# M Y* N 6 ND 514 c.1319delT; 
c.1032_1117dup
FS/del; FS/dup
#Proband; *hearing impairment; ¶The patient had syncope once or twice a year as a child but no syncope after 30-y-o; “F” stands for female, “M” stands for male; “N” stands 
for no deafness or no SCD; “ND” stands for no data; FS: Frame shift; del: Deletion; ins: Insertion; SNP: Single nucleatide polymorphism70  Journal of Cardiovascular Disease Research Vol. 3 / No 2
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a heterozygous p.Gly272Asp and the mother carried a 
heterozygous c.605-2A>G [Figure 2]. These two mutations 
were absent in 100 control alleles.
Clinical characteristics and mutation finding in Family 
L151
The proband of Miao descent family L151 was a 46-year-old 
man with congenital deafness, a history of recurrent syncope 
and borderline QTc prolongation (460 ms). Starting at the age 
of 2, he experienced syncope 1–2 times per year until the age 
of 30 and none thereafter without any etiotropic treatment. 
His 17-year-old daughter, although with normal hearing, was 
very symptomatic. At age 2, she was diagnosed with epilepsy 
and treated with Phenobarbital (30–60 mg/day). While on 
Phenobarbital, she experienced five more seizure-like attacks, 
triggered by physical or mental stress. At age 12, she was 
diagnosed with LQTS and treated with Metoprolol 25 mg/
day (the equivalent of 0.725 mg/kg of Propranolol). Her QTc 
on serial ECGs ranged from 480 to 530 ms [Figure 3]. During 
the third year of beta-blocker treatment, she experienced 
another syncopal episode, evoked by exercise. Metoprolol 
dosage was therefore adjusted to 50 mg/day (the equivalent 
of 1.45 mg/kg of Propranolol) and she has remained event-
free for the last 2 years. Family screening revealed that one of 
her aunts was congenitally deaf and died suddenly at age 33. 
Both paternal grandparents had QTc of 506 ms, although 
they had never experienced any cardiac events. There was no 
consanguineous marriage in the family.
Compound heterozygous mutations c.1032G>A 
(p.Ala344Alasp) and c.569G>A (p.Arg190Gln) were 
identified in the proband. His daughter, who displayed a 
RWS phenotype, inherited c.1032G>A (p.Ala344Alasp) 
from him and novel missense mutation c.574C>T 
(p.Arg192Cys) from her mother who was a silent mutation 
carrier. A rare single nucleotide polymorphism (SNP), 
c.253G>A (p.Asp85Asn) in KCNE1, was found in the 
proband, his mother, sister and daughter [Figure 4]. 
c.253G>A (p.Asp85Asn; rs1805128) and the three 
pathogenic mutations identified in kindred L151 were 
absent in 100 control alleles.
Clinical characteristics and mutation finding in Family 
L155
The proband for L155 was a 16-year-old boy with 
significant hearing loss and required the use of a hearing 
aid. Between the ages of 6 and 16, he experienced four 
exercise-induced syncopal episodes. His ECG showed 
marked sinus bradycardia and a prolonged QTc of 620 
Figure 2: The mutations in kindred L148. (a) shows an A-to-G change 
at nucleotide position A605-2, which resulted in a splice site alteration 
c.605-2A>G. The starting point of the coding domain for exon 3 of 
KCNQ1 is marked in the rectangle. (b) shows a G to A change at 
position 815, which is a known mutation p.Gly272Asp, previously 
reported in a Romano-Ward syndrome European patient. (c) shows 
the family tree for L148, where two mutations were transmitted from 
both parents. The paternal lineage carries a heterozygous p.Gly272Asp 
(Red) only, while the maternal lineage carries a heterozygous c.605-
2A>G (Blue).
Figure 1: The 12-lead electrocardiogram (ECG) for probands from 
kindred L148. (a) ECG for L148-01, a 12-year-old girl: The left two ECGs 
showed very broad and notched or bifid even biphasic T waves on 
multi-leads (arrows) (QTc 590 ms) before she had received left cardiac 
sympathetic denervation (LCSD); the right one showed less abnormal 
ECG 15 months after LCSD (QTc 490 ms). (b) ECG for L148-02, a 
5-year-old boy: The left one showed very broad and notched or bifid 
even biphasic T waves on multi-leads (arrows) (QTc 600 ms) before 
he had received left cardiac sympathetic denervation (LCSD); the right 
one showed less abnormal ECG 15 months after LCSD (QTc 490 ms).
a b
b a
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ms [Figure 5]. Since being diagnosed with JLNS, he 
has been treated with Propranolol (2.0 mg/kg) and a 
pacemaker, and has remained event-free. His parents 
Figure 5: The 12-lead electrocardiogram (ECG) for the proband of 
L155. The proband is a 16-year-old boy: The left ECG showed very 
broad and notched or bifid even biphasic T waves on multi-leads 
(arrows) (QTc 620 ms) before he had received a pacemaker; the right 
one showed less abnormal ECG 5 months after pacemaker+propranolol 
2 mg/Kg (QTc 514 ms).
had normal QT intervals and their marriage was not 
consanguineous.
Two novel complex mutations were found in the proband 
of kindred L155: c.1032_1117dup (p.Ser373TrpfsX10), a 
frameshift mutation causing a truncated protein containing a 
total of 381 amino acids, and c.1319delT (p.Val440AlafsX26), 
another frameshift mutation resulting in a truncated protein, 
containing a total of 464 amino acids. His father carries a 
heterozygous p.Ser373TrpfsX10 only, while the mother 
carries a heterozygous p.Val440AlafsX26 [Figure 6]. These 
two mutations were absent in 100 control alleles.
The bizarre T waves in Chinese patients with JLNS
Marked QT prolongation associated with bizarre T waves 
(broad, bifid, notched or biphasic) was seen on 3/4 JLNS 
patients [Figures 1 and 5]. These ECG abnormalities were 
more prominent when patients were symptomatic, and 
improved after treatment. One individual who did not 
demonstrate such T wave anomalies was the proband of 
L151, a 46-year-old male with borderline QTc prolongation 
(460 ms) who has been event-free for the past 16 years.
DISCUSSION
There have been four reports regarding JLNS-causing 
mutations in Asian patients thus far,[11-13,18] all found in 
Figure 4: The mutations detected in kindred L151. (a) shows a novel 
mutation, c.574C>T, discovered in the LQT1 daughter (pink arrow) and 
a known mutation c.569G>A found in the Jervell and Lange-Nielsen 
syndrome father (gray arrow). (b) shows a mutation c.1032G>A (arrow) 
found in both the daughter and father, which induced a splicing error. 
The ending point of the coding domain for exon 7 of KCNQ1 is marked in 
the rectangle. (c) shows the conservation across species for c.569G>A 
and c.574C>T. (d) shows the family tree for L151. Blue represents 
c.1032G>A, Green c.569G>A, Red c.574C>T, Black D85N-KCNE1 
(Sequence not shown).
d
a b
c d
Figure 3: The 12-lead electrocardiogram (ECG) for patients from 
kindred L151: (a) ECGs for L151-01, now a 17-year-old girl: The left 
ECG was recorded when she was 12 years old and diagnosed as 
having Long QT syndrome (QTc 480 ms); the right one was recorded 
when she was 16 years old and taking metoprolol 0.69 mg/Kg (QTc 
530 ms). (b) ECG for the 46-year-old Jervell and Lange-Nielsen 
syndrome proband: The only abnormality is QT prolongation (QTc 
460 ms) for him. He has no syncope after his 30’s. No ECG was 
available for his young ages when he had syncope.
a b72  Journal of Cardiovascular Disease Research Vol. 3 / No 2
Gao, et al.: Chinese families with JLNS
that two KCNQ1 mutations can result in a severe variant 
of RWS in Chinese.
Furthermore, we found that the degree of ECG 
abnormalities seen in our JLNS patients was associated with 
the severity of their clinical manifestations. After effective 
treatments such as beta-blockers, left cardiac sympathetic 
denervation, or pacemakers, improvement was gauged 
by reduced syncopal episodes and less abnormal T wave 
morphologies on ECG readings.
Of the 31 JLNS-causing mutations previously reported 
[Table 2 and Figure 7], three were splicing, three nonsense, 
14 missense, and 11 were frameshift (insertion/deletion) 
mutations. In the present study, we have identified two 
additional splice mutations, c.605-2A>G and c.1032G>A 
combined with c.815G>A and c.569G>A, respectively, 
in two Chinese families with JLNS. Kapplinger et al.,[20] 
reported in 2009 that c.605-2A>G was an LQTS-causing 
mutation, while the c.1032G>A transition was described by 
Murray et al.,[21] and by six other groups[22-27] as a cause of 
LQTS. However, each of these previous studies identified 
single mutations as causes of RWS. Our study on the 
other hand, demonstrates that when seen as compound 
mutations, they can also cause JLNS.
The two novel complex mutations identified in this study, 
c.1032_1117dup and c.1319delT, expanded the total number 
of JLNS-causing frameshift mutations in KCNQ1 to 13.
A diverse genotype/phenotype presentation was found 
in kindred L151 [Figures 3 and 4]. Inherited from each 
parent, the proband carried compound KCNQ1 mutations 
and showed a JLNS phenotype. Unlike most JLNS cases, 
he showed a mild QT interval prolongation (460 ms) and 
has been event-free for the last 16 years. This finding 
may imply that with increasing age, cardiac event rates 
may decrease over time in patients with JLNS, a trend 
KCNQ1. Zhang et al.,[12] identified a homozygous mutation 
T322M in two Chinese siblings; Ohno S et al.,[11] described 
another homozygous mutation W248F in a Japanese family 
in 2008. Baek JS et al.,[18] reported compound heterozygous 
mutation V307sp/S277del in a Korean family in 2010, and 
Wang RR et al.,[13] described T2C/1149insT in a young 
Chinese female in 2011. In light of the three additional 
pairs of compound heterozygous mutations identified in 
Chinese patients with JLNS in this study, it appears that 
compound mutations in KCNQ1 may be a primary cause 
of JLNS among Chinese individuals.
Among the newly identified mutations, c.1032_1117dup 
and c.1319delT are novel, and c.569G>A, c.605-2A>G, 
c.815G>A, c.1032G>A are known mutations, previously 
described in patients with RWS. Interestingly, we found 
that novel heterozygous mutation c.574C>T evoked a 
RWS phenotype within a JLNS lineage when joined with 
c.1032G>A. It should be noted that in Itoh H. et al.’s 2010 
study,[19] two out of three of their probands with two 
KCNQ1 mutations presented without deafness but with 
severe phenotypes of RWS. Our work further demonstrates 
Figure 7: The distribution of mutations within the KCNQ1 channel: 
(a) Mutations identified in our study: Kindred L148 (blue), kindred 
L151 (green), kindred L155 (red); (b) Mutations detected previously by 
other scientists: Frameshift/Deletion/Splice errors are marked in red; 
Missense/Nonsense are marked in black.
a b
a b
Figure 6: The mutations detected in kindred L155. (a) shows a novel 
mutation, c.1032_1117dup on exon 8, resulting in a truncated protein 
containing a total of 381 amino acids. (b) shows another novel deletion 
mutation, 1319 delT on exon 10, resulting in a truncated protein 
containing a total of 464 amino acids. The paternal lineage carried 
a heterozygous p.Ser373TrpfsX10 only, while the maternal lineage 
carried a heterozygous p.Val440AlafsX26. (c) shows the family tree 
for L155. The father carried a heterozygous c.1032_1117dup (blue), 
while the mother a heterozygous 1319 delT (red).
c
a
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generally seen in most patients with RWS. The proband’s 
parents were silent single-gene mutation carriers and both 
only presented with markedly prolonged QT intervals. 
His daughter carried a slightly different set of KCNQ1 
compound mutations and presented with a severe RWS 
phenotype: A significantly prolonged QT interval (530 ms), 
and recurrent syncope, but without hearing impairment. 
This observation is consistent with other findings that 
compound mutations of KCNQ1 do not necessarily 
lead to JLNS. In 2008, Bhuiyan ZA et al.,[28] described a 
homozygous intronic mutation (c387-5T>A) that led to 
an incomplete skipping of exon-2 in KCNQ1 and rescued 
hearing in an Arabian JLNS patient. This indicated that 
while a small amount (as little as 10%) of normal KCNQ1 
current function was unable to maintain normal cardiac 
repolarization characteristics, it was enough to effectively 
maintain hearing function. Furthermore, Kanovsky J 
et al.,[29] reported a homozygous mutation (R190L) that 
led to a diagnosis of incomplete JLNS (subclinical hearing 
impairment) in a 19-year-old female in 2010. Yet, her 
older sister, who carried the same mutation and presented 
with similar symptoms, displayed physiologically normal 
audiometry findings. The mechanism underlying this 
significant difference could be that some genetic modifiers 
(yet unknown), when combined with a primary mutation, 
may exacerbate a patient’s phenotype.[30,31]
The allele frequencies of KCNE1-D85N i.e. c.253G>A 
(p.Asp85Asn), according to Ackerman et al.,[32] are 0.7% 
in Blacks, 0.7% in Asians, 1.1% in Caucasians, and 0.0% 
Table 2: JLNS-related mutations
Nucleotide change Amino acid change* Mutation type Region Phenotype Reference
T2C – Frameshift/deletion S1 JLNS Wang RR et al., 2011
451-452delCT L151fs+283X Frameshift/deletion S2 JLNS Chen et al., 1999
477+1 G>A M159 Splice error S2 JLNS +RWS Donger et al., 1997
G502A G168R Missense S2 RWS+JLNS Donger et al., 1997
C513G Y171X Nonsense S2-S3 JLNS  Piippo et al., 2001
insG567 G189 Frameshift/insertion S2-S3 RWS+JLNS Splawski et al., 1997
G569T R190L Missense S2-S3 RWS+JLNS Kanovsky J, 2009
c.569G>A (L151) p.Arg190Gln Missense S2-S3 RWS+JLNS Wang Q, 1996; this study
572-576del L191fs281X Frameshift/deletion S2-S3 JLNS+RWS Tyson J, 2000
585delG R195fs+40X Frameshft/deletion S2-S3 JLNS Wang Z et al, 2002 
G604A D202N Missense S3 JLNS Wang Z et al, 2002 
c.605-2A>G(L148) D202sp Splice error S3 JLNS This study
G728A R243H Missense S4-S5 RWS+JLNS Tyson J, 2000
G743T-G744C W248F Missense S4-S6 JLNS Ohno et al., 2008
G783C E261D Missense S4-S5 JLNS Tyson J, 2000
G806A G269D Missense S5 JLNS Wang Z et al, 2002 
c.815G>A (L148) p.Gly272Asp Missense S5 JLNS Tyson J 2000, this study
828-830delCTC S277del Missense S5 JLNS Baek JS et al, 2010
G914C W305S Missense Pore JLNS Neyroud et al., 1998
G917T  G306V Missense Pore RWS+JLNS Liu W et al, 2002
921G>A V308sp Splice error Pore JLNS Baek JS et al, 2010
C965T T322M Missense Pore-S6 JLNS Zhang S, 2008
1008delC A337fs+16 Frameshift/deletion S6 JLNS Tyson J, 2000
c.1032_1117dup(L155) p.Ser373TrpfsX10 Frameshift/duplication C-term JLNS This study
c.1032G>A (L151) p.Ala344Alasp Splice error S6 JLNS This study
1149insT A384fs/79 Frameshift/deletion C-term JLNS Wang RR et al., 2011
1188delC I396sfX418 Frameshift/deletion C-term JLNS Wei et al., 2000
1244, -7 +8 Q415fs+107X Frameshift/deletion C-term JLNS Neyround N et al, 1997
c.1319delT (L155) p.Val440AlafsX26 Frameshift/deletion C-term JLNS This study
C1552T R518X (2) Nonsense C-term JLNS;  Tyson J, 2000
C1588T  Q530X (2) Nonsense C-term JLNS Tyson J, 2000
1630 del6/ins7 E543fsX650 Frameshift C-term JLNS Neyroud et al, 1997
G1686-1A R562fs+30X Splice site C-term JLNS Tyson J, 2000
C1760T T587M Missense C-term RWS+JLNS Neyroud et al., 1999
G1766A G589D Missense C-term RWS+JLNS Piippo et al, 2001
1781 G→A  R594Q Missense C-term JLNS Tyson J, 2000
1892del20 P631fsX644 Frameshift/deletion C-term JLNS Neyroud et al., 1999
*Notes: The aminoacid changes for frameshift mutations shown here may not comply with the same mutation nomenclature as mentioned in the methods section. They are quoted 
here as they appeared in their original reports74  Journal of Cardiovascular Disease Research Vol. 3 / No 2
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in Hispanics. Additional data from 95 unrelated Han 
Chinese individuals (50 in the present study and 45 from the 
International HapMap project[33]) indicates that the allele 
frequency is 0.0% in the Chinese population. A number 
of studies have demonstrated that D85N can cause loss of 
function to both IKr (the rapidly activating delayed rectifier 
K+ channel) and IKs, suggesting that it might function as 
a disease-causing variant.[34-36] In the present study, both 
the proband of L151 and his daughter carried a couple 
of compound mutations on KCNQ1 accompanied by a 
SNP of D85N on KCNE1, but the daughter maintained 
normal hearing. It is our hope that the more severe LQTS 
phenotype seen in the father can help support Lahtinen 
AM et al.’s[37] proposition that the KCNE1-D85N mutation 
might preferentially affect males.
The identification of mutations and the investigation of 
genotype-phenotype relationships of channelopathies 
have become focal points in the field of genetics and 
cardiology.  [38] Although the molecular genetic mechanisms 
underlying JLNS remain elusive, important progress has 
been made. With this study, we have expanded the mutation 
and phenotype spectrum of JLNS and we have substantiated 
the important role that compound heterozygous mutations 
play in the disease. Furthermore, we have documented 
clinical outcomes and salient ECG irregularities from our 
patients that with further research may potentially prove to 
be useful in evaluating the clinical severity of JLNS.
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